May 2 - 5
Visit us at Booth #1005 to Discover
Artivion’s EDGE
Jump to a section to learn more:
Lunch Symposium
Resetting the Standard:
Transforming Patient Care
with Advanced Aortic Technologies
Friday, May 2nd
12:00 PM – 1:00 PM
Room #420-422
Add event to calendar
Dr. William Brinkman
Baylor Scott & White Health, USA
Dr. S. Chris Malaisrie
A Data-Driven Valve Strategy for Younger AVR Patients
Northwestern University, USA
Dr. Shinichi Fukuhara
The Role of AMDS in ADTI Treatment and Results from the PERSEVERE US IDE Study
University of Michigan, USA
Dr. Michael Moon
Importance of Patient Selection and Reintervention Options with AMDS
University of Alberta, Canada
This is an industry-supported symposium and is not part of the AATS Annual Meeting accredited program. To attend this lunch symposium, you must be registered for the AATS Annual Meeting.
Podium Presentations
Late-Breaker Presentations:
Impact of Supra-Aortic Vessel False Lumen Communications on Aortic Remodeling: Analysis from the PERSEVERE Trial
Session: Adult Cardiac: Aortic Device Late Breakers, Exhibit Hall
Saturday, May 3rd
12:27 PM PT
Seattle Convention Center | Summit, Summit Theater 3, Exhibit Hall
University of Alabama Birmingham
Endovascular Aortic Arch Repair Using a Novel Single-Branch Arch Stent Graft for Chronic Dissection: 30-Day Outcomes of the TRIOMPHE FDA Pivotal Study
Session: Adult Cardiac: Aortic Device Late Breakers, Exhibit Hall
Saturday, May 3rd
12:15 PM PT
Seattle Convention Center | Summit, Summit Theater 3, Exhibit Hall
Emory University School of Medicine
Clinical Data
Artivion’s aortic-centric product portfolio is powered by compelling clinical evidence. Watch the video below to see how our products give surgeons the edge in treating aortic disease.
All products and indications are not available / approved in all markets.
AMDS is RX Only: Humanitarian Use Device. Authorized by Federal Law for use in the treatment of acute DeBakey Type I Aortic Dissection. The effectiveness of this device for this use has not been demonstrated.
NEXUS is an Investigational Device Limited by United States law to investigational use.
Refer to the device’s Instructions for Use for indications, contraindications, warnings, precautions, and possible complications. NEXUS® is a registered trademark of Endospan Ltd. All other trademarks are owned by Artivion, Inc. or its subsidiaries. © 2025 Artivion, Inc. All rights reserved.